Indication
Anal intraepithelial neoplasia 2/3
2 clinical trials
2 products
Product
PlaceboClinical trial
A Phase II Double Blind, Placebo-controlled, Randomized Trial of Artesunate Suppositories for the Treatment of HIV-negative Patients With Anal High-grade Squamous Intraepithelial Lesions (Anal HSIL)Status: Active (not recruiting), Estimated PCD: 2024-02-28
Product
ArtesunateClinical trial
A Phase II Double Blind, Placebo-controlled, Randomized Trial of Artesunate Ointment for the Treatment of HIV-negative Patients With Anal High-grade Squamous Intraepithelial Lesions (Anal HSIL)Status: Recruiting, Estimated PCD: 2025-12-31